Digitek Plaintiffs Want 2nd Look At Class Cert.

By Richard Vanderford (June 10, 2010, 1:27 PM EDT) -- Plaintiffs who lost a bid for class certification in multidistrict litigation over the recall of Actavis Inc. and Mylan Inc.'s heart drug Digitek have asked the judge to reconsider his decision, saying he did not understand what they want from their cases....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!